Literature DB >> 28697378

Changes in phagocytosis and potassium channel activity in microglia of 5xFAD mice indicate alterations in purinergic signaling in a mouse model of Alzheimer's disease.

Stefan Wendt1, Meron Maricos1, Natascha Vana1, Niklas Meyer1, Dilansu Guneykaya1, Marcus Semtner1, Helmut Kettenmann2.   

Abstract

As the immunocompetent cells of the central nervous system, microglia accumulate at amyloid beta plaques in Alzheimer's disease (AD) and acquire a morphological phenotype of activated microglia. Recent functional studies, however, indicate that in mouse models of amyloidosis and AD, these cells are rather dysfunctional indicated by a reduced phagocytic activity. Here, we report that this reduction in phagocytic activity is associated with perturbed purinergic receptor signaling, since phagocytosis could be stimulated by P2Y6 receptor activation in control, but not in 5xFAD transgenic animals, an animal model of amyloid deposition. Impaired phagocytosis is not innate, and develops only at later stages of amyloidosis. Furthermore, we show that membrane currents induced by uridine diphosphate, a ligand activating P2Y6 receptors, are altered in response rate and amplitude in microglia in close vicinity to plaques, but not in plaque-free areas of 5xFAD animals. These changes were accompanied by changes in membrane properties and potassium channel activity of plaque-associated microglia in early and late stages of amyloidosis. As a conclusion, the physiological properties of plaque-associated microglia are altered with a strong impact on purinergic signaling.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5xFAD; ATP; Abeta plaque; Alzheimer; Membrane currents; Microglia; Phagocytosis; Purinergic responses; UDP

Mesh:

Substances:

Year:  2017        PMID: 28697378     DOI: 10.1016/j.neurobiolaging.2017.05.027

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

1.  The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse Microglia.

Authors:  Nirmeen Elmadany; Felipe de Almeida Sassi; Stefan Wendt; Francesca Logiacco; Josien Visser; Verena Haage; Daniel Perez Hernandez; Philipp Mertins; Dolores Hambardzumyan; Susanne Wolf; Helmut Kettenmann; Marcus Semtner
Journal:  J Neurosci       Date:  2020-02-14       Impact factor: 6.167

Review 2.  Glial Purinergic Signaling in Neurodegeneration.

Authors:  Marie J Pietrowski; Amr Ahmed Gabr; Stanislav Kozlov; David Blum; Annett Halle; Kevin Carvalho
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

3.  Targeting Microglial Population Dynamics in Alzheimer's Disease: Are We Ready for a Potential Impact on Immune Function?

Authors:  Maria Martin-Estebane; Diego Gomez-Nicola
Journal:  Front Cell Neurosci       Date:  2020-06-05       Impact factor: 5.505

Review 4.  Microglia in Alzheimer's Disease: A Role for Ion Channels.

Authors:  Laura Thei; Jennifer Imm; Eleni Kaisis; Mark L Dallas; Talitha L Kerrigan
Journal:  Front Neurosci       Date:  2018-09-28       Impact factor: 4.677

Review 5.  Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases.

Authors:  Shehata Anwar; Vincent Pons; Serge Rivest
Journal:  Cells       Date:  2020-07-01       Impact factor: 6.600

6.  The microglial activation profile and associated factors after experimental spinal cord injury in rats.

Authors:  Yuan Zhou; Ning Li; Lin Zhu; Yixing Lin; Huilin Cheng
Journal:  Neuropsychiatr Dis Treat       Date:  2018-09-20       Impact factor: 2.570

7.  Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms.

Authors:  Yang Shi; Prabhakar Sairam Andhey; Christina Ising; Kairuo Wang; Lisa L Snipes; Kevin Boyer; Stephanie Lawson; Kaoru Yamada; Wei Qin; Melissa Manis; Javier Remolina Serrano; Bruno A Benitez; Robert E Schmidt; Maxim Artyomov; Jason D Ulrich; David M Holtzman
Journal:  Neuron       Date:  2021-06-21       Impact factor: 18.688

8.  Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of Nf1 low-grade glioma growth.

Authors:  Yuan Pan; Min Xiong; Ran Chen; Yu Ma; Courtney Corman; Meron Maricos; Urs Kindler; Marcus Semtner; Yi-Hsien Chen; Sonika Dahiya; David H Gutmann
Journal:  Genes Dev       Date:  2018-04-09       Impact factor: 11.361

9.  P2Y6 receptor inhibition aggravates ischemic brain injury by reducing microglial phagocytosis.

Authors:  Ruo-Xue Wen; Hui Shen; Shu-Xian Huang; Li-Ping Wang; Zong-Wei Li; Peng Peng; Muyassar Mamtilahun; Yao-Hui Tang; Fan-Xia Shen; Heng-Li Tian; Guo-Yuan Yang; Zhi-Jun Zhang
Journal:  CNS Neurosci Ther       Date:  2020-03-10       Impact factor: 5.243

10.  The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice.

Authors:  Johanna Michael; Julia Zirknitzer; Michael Stefan Unger; Rodolphe Poupardin; Tanja Rieß; Nadine Paiement; Horst Zerbe; Birgit Hutter-Paier; Herbert Reitsamer; Ludwig Aigner
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.